Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. | Am J Hosp Palliat Care;22(3): 228-32, 2005. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.

Mystakidou, Kyriaki; Katsouda, Emmanuela; Parpa, Efi; Tsiatas, Marinos L; Vlahos, Lambros.

Affiliation

Mystakidou K; Department of Radiology, University of Athens, Athens, Greece.

Am J Hosp Palliat Care ; 22(3): 228-32, 2005.

Article in En | MEDLINE | ID: mdl-15909786

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pain, Intractable / Fentanyl / Analgesics, Opioid / Neoplasms Type of study: Etiology_studies Limits: Humans Language: En Journal: Am J Hosp Palliat Care Journal subject: ENFERMAGEM Year: 2005 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pain, Intractable / Fentanyl / Analgesics, Opioid / Neoplasms Type of study: Etiology_studies Limits: Humans Language: En Journal: Am J Hosp Palliat Care Journal subject: ENFERMAGEM Year: 2005 Document type: Article Affiliation country: Country of publication: